Genomics England

Genomics England
Genomics England logo
Parent organization
 Department of Health
Website genomicsengland.co.uk

Genomics England is a company set up and owned by the UK Department of Health to run the 100,000 Genomes Project,[1] which aims to sequence 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. An infectious disease strand is being led by Public Health England.[2][3][4]

Activity

Genomics England was formally established as a company on 17 April 2013[5] and was formally launched on 5 July 2013 as part of the celebrations for the 65th Birthday of the UK's National Health Service [6] In August 2014, the Wellcome Trust announced that it was investing £27 million in a genome-sequencing hub for Genomics England, allowing the company to become part of the Wellcome Trust Genome Campus, home to the Sanger Institute. On the same date, Prime Minister David Cameron unveiled a new partnership between Genomics England and the sequencing firm Illumina. Illumina’s services for whole genome sequencing were secured in a deal worth around £78million.[7]

The UK Government also committed £250 million to genomics in the 2015 Spending Review, which ensures the continued role of Genomics England to deliver the project, beyond the life of the project and up to 2021.[8]

Board Members

The Board of Genomics England includes a number of notable scientists:[9]

In addition to the delivery of the 100,000 Genomes Project, it is hoped that Genomics England will also mark the beginnings of a UK genomics industry and the start of a personalised medicine service for the NHS.[11]

History

Genomics England was established in July 2013 as a company fully owned by the UK Department of Health.[11][12][13] The company was launched by Jeremy Hunt, Secretary of State for Health on 5 July, in an announcement timed to coincide with the 65th birthday of the NHS.[13]

See also

100,000 Genomes Project

References

  1. ↑ McGrath, J.A. (2016). "Rare inherited skin diseases and the Genomics England 100 000 Genome Project". British Journal of Dermatology. 174 (2): 257–258. doi:10.1111/bjd.14362. ISSN 0007-0963.
  2. ↑ Moran, Nuala (2014). "10,000 rare-disease genomes sequenced". Nature Biotechnology. 32 (1): 7–7. doi:10.1038/nbt0114-7. ISSN 1087-0156.
  3. 1 2 Ainsworth, Claire (2015). "Q&A: Mark Caulfield". Nature. 527 (7576): S5–S5. doi:10.1038/527S5a. ISSN 0028-0836.
  4. ↑ Marx, Vivien (2015). "The DNA of a nation". Nature. 524 (7566): 503–505. doi:10.1038/524503a. ISSN 0028-0836.
  5. ↑ "GENOMICS ENGLAND LIMITED". Companies House. Retrieved 3 December 2017.
  6. ↑ "DNA mapping to better understand cancer, rare diseases and infectious diseases". Department of Health (England) . 5 July 2013. Retrieved 3 December 2017.
  7. ↑ Gallagher, James (1 August 2014). "DNA project 'to make UK world genetic research leader'". BBC News. Retrieved 1 August 2014.
  8. ↑ "Cancer patients join genome sequencing project - News stories - GOV.UK". www.gov.uk. Retrieved 2016-06-06.
  9. ↑ "The Board - Genomics England". genomicsengland.co.uk. Retrieved 12 September 2014.
  10. ↑ "Professor Ewan Birney appointed to the Genomics England Board | Genomics England". Genomics England. 2016-05-26. Retrieved 2016-06-06.
  11. 1 2 "Jeremy Hunt launches genomics body to oversee healthcare revolution". theguardian.com. The Guardian. Retrieved 12 September 2014.
  12. ↑ "Jeremy Hunt launches genomics body to oversee healthcare revolution". theguardian.com. The Guardian. Retrieved 12 September 2014.
  13. 1 2 "DNA mapping to better understand cancer, rare diseases and infectious diseases". UK Government. 2013-07-05. Retrieved 2016-05-26.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.